Tysabri Registry Monthly Reports And Patient Checklist Follow-Up Advised

Biogen Idec should receive monthly reports from its Tysabri risk management patient registry on checklists filled out prior to infusion, members of FDA's Peripheral & Central Nervous System Drugs Advisory Committee recommended March 8